Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSPA5 | P11021 | 2/20 | 0.72 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.70 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.70 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.70 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.70 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | CA2 | P00918 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | TYR | P14679 | 1/20 | 0.53 |
| ▸ | BCL2 | P10415 | 1/20 | 0.50 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.43 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.43 |
| ▸ | PTPN6 | P29350 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4565241 | 0.94 | HSPA5 (0.64) | HSPA5CYP2C9CYP2C19HIF1ASMN1; SMN2 | |
| SCHEMBL4456953 | 0.90 | HSPA5 (0.59) | HSPA5CYP2C9CYP2C19HIF1ASMN1; SMN2 | |
| Phenol SCHEMBL23706530 | 0.87 | HSPA5 (0.77) | HSPA5CYP2C9CYP2C19HIF1ASMN1; SMN2 | |
| SCHEMBL8377432 | 0.87 | HSPA5 (0.72) | HSPA5CYP2C9CYP2C19HIF1ASMN1; SMN2 | |
| Phenol SCHEMBL10629108 | 0.86 | CYP2C9 (0.78) | HSPA5CYP2C9CYP2C19HIF1ASMN1; SMN2 | |
| SCHEMBL12309162 | 0.86 | HSPA5 (0.60) | HSPA5CYP2C9CYP2C19HIF1ASMN1; SMN2 | |
| SCHEMBL9817016 | 0.85 | HSPA5 (0.60) | HSPA5CYP2C9CYP2C19HIF1ASMN1; SMN2 | |
| SCHEMBL9950640 | 0.85 | HSPA5 (0.79) | HSPA5CYP2C9CYP2C19HIF1ASMN1; SMN2 | |
| SCHEMBL8772330 | 0.85 | HSPA5 (0.79) | HSPA5CYP2C9CYP2C19HIF1ASMN1; SMN2 | |
| SCHEMBL12309158 | 0.85 | HSPA5 (0.79) | HSPA5CYP2C9CYP2C19HIF1ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-3993782-A | ALKYL-2-BENZYL-PHENOLS | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 1976-11-23 | — | — | US | claimed |
| US-9260358-B2 | Process for oligomerization of olefins that uses a catalytic composition that comprises an organometallic complex that contains a phenoxy ligand that is functionalized by a heteroatom | IFP Energies Nouvelles (FR) | 2016-02-16 | — | — | US | disclosed |
| US-9260358-B2 | Process for oligomerization of olefins that uses a catalytic composition that comprises an organometallic complex that contains a phenoxy ligand that is functionalized by a heteroatom | IFP Energies Nouvelles (FR) | 2016-02-16 | — | — | US | disclosed |
| US-20110213190-A1 | PROCESS FOR OLIGOMERIZATION OF OLEFINS THAT USES A CATALYTIC COMPOSITION THAT COMPRISES AN ORGANOMETALLIC COMPLEX THAT CONTAINS A PHENOXY LIGAND THAT IS FUNCTIONALIZED BY A HETEROATOM | IFP (FR) | 2011-09-01 | — | — | US | disclosed |
| US-20110213190-A1 | PROCESS FOR OLIGOMERIZATION OF OLEFINS THAT USES A CATALYTIC COMPOSITION THAT COMPRISES AN ORGANOMETALLIC COMPLEX THAT CONTAINS A PHENOXY LIGAND THAT IS FUNCTIONALIZED BY A HETEROATOM | IFP (FR) | 2011-09-01 | — | — | US | disclosed |
| US-7622247-B2 | Protective overcoats for thermally developable materials | CARESTREAM HEALTH, INC. (US) | 2009-11-24 | — | — | US | disclosed |
| US-20090181332-A1 | PROTECTIVE OVERCOATS FOR THERMALLY DEVELOPABLE MATERIALS | TROPHY DENTAL INC. | 2009-07-16 | — | — | US | disclosed |
| US-7514206-B2 | Thermally developable materials with buried conductive backside coatings | CARESTREAM HEALTH, INC. (US) | 2009-04-07 | — | — | US | disclosed |
| US-7468241-B1 | Processing latitude stabilizers for photothermographic materials | CARESTREAM HEALTH, INC. (US) | 2008-12-23 | — | — | US | disclosed |
| WO-2008142295-A1 | METHOD FOR OLIGOMERISING OLEFINS USING A CATALYTIC COMPOSITION COMPRISING AN ORGANOMETAL COMPLEX CONTAINING A PHENOXY LIGAND FUNCTIONALISED BY A HETEROATOM | IFP (FR) | 2008-11-27 | — | — | WO | disclosed |
| US-5171657-A | Containing photopolymerizable monomer | CANON KABUSHIKI KAISHA (JP) | 1992-12-15 | — | — | US | disclosed |
| EP-0461621-A2 | Image forming method | CANON KABUSHIKI KAISHA (JP) | 1991-12-18 | — | — | EP | disclosed |
| EP-0453125-A2 | Image forming method and image forming apparatus | CANON KABUSHIKI KAISHA (JP) | 1991-10-23 | — | — | EP | disclosed |
| US-5021321-A | Photothermography; antifogging agents; contrast; lamination of matrix of silver salts and reducing agent and dispersed particles of dye, polymer precursor and photoinitiator | CANON KABUSHIKI KAISHA (JP) | 1991-06-04 | — | — | US | disclosed |
| EP-0412851-A2 | Photosensitive member and multi-color image forming method | CANON KABUSHIKI KAISHA (JP) | 1991-02-13 | — | — | EP | disclosed |
| EP-0363790-A2 | Image forming method and image forming medium | CANON KABUSHIKI KAISHA (JP) | 1990-04-18 | — | — | EP | disclosed |
| US-4247427-A | Adhesion promoted block copolyester composition with multi-functional carboxylic compound | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1981-01-27 | — | — | US | disclosed |
| US-4156702-A | Adhesion promoted block copolyester composition with multi-functional carboxylic compound | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1979-05-29 | — | — | US | disclosed |
| US-4048128-A | ALKALINE EARTH OXIDE, POLYCARBODIIMIDE | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1977-09-13 | — | — | US | disclosed |
| US-3969294-A | Segmented copolyester adhesives stabilized by alkaline earth oxides and carboxylic compounds | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1976-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110213190-A1 | PROCESS FOR OLIGOMERIZATION OF OLEFINS THAT USES A CATALYTIC COMPOSITION THAT COMPRISES AN ORGANOMETALLIC COMPLEX THAT CONTAINS A PHENOXY LIGAND THAT IS FUNCTIONALIZED BY A HETEROATOM | HAO2, CPNE4, POF1B | HSPA5 2892/4885CYP2C9 1199/4885CYP2C19 1025/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.